Home

Posters sap weg msi high colon cancer immunotherapy België Boren Hysterisch Verslaving

Cells | Free Full-Text | Impact of Pre-Analytical Factors on MSI Test  Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance  Study | HTML
Cells | Free Full-Text | Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study | HTML

PDF) The degree of microsatellite instability predicts response to PD-1  blockade immunotherapy in mismatch repair-deficient/microsatellite  instability-high colorectal cancers
PDF) The degree of microsatellite instability predicts response to PD-1 blockade immunotherapy in mismatch repair-deficient/microsatellite instability-high colorectal cancers

Checkpoint Inhibition: A Promising Immunotherapeutic Approach for  Colorectal Cancer | Personalized Medicine in Oncology
Checkpoint Inhibition: A Promising Immunotherapeutic Approach for Colorectal Cancer | Personalized Medicine in Oncology

Microsatellite instable vs stable colon carcinomas: analysis of tumour  heterogeneity, inflammation and angiogenesis | British Journal of Cancer
Microsatellite instable vs stable colon carcinomas: analysis of tumour heterogeneity, inflammation and angiogenesis | British Journal of Cancer

Frontline pembrolizumab delays disease progression of colorectal cancer  patients with a high microsatellite instability - BJMO
Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO

References in International validation of the consensus Immunoscore for the  classification of colon cancer: a prognostic and accuracy study - The Lancet
References in International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study - The Lancet

PDF) Immunotherapy with immune checkpoint inhibitors in colorectal cancer:  What is the future beyond deficient mismatch-repair tumours?
PDF) Immunotherapy with immune checkpoint inhibitors in colorectal cancer: What is the future beyond deficient mismatch-repair tumours?

PEMBROLIZUMAB AS A NEW, FIRST-LINE STANDARD OF CARE IN COLORECTAL CANCER -  BJMO
PEMBROLIZUMAB AS A NEW, FIRST-LINE STANDARD OF CARE IN COLORECTAL CANCER - BJMO

International validation of the consensus Immunoscore for the  classification of colon cancer: a prognostic and accuracy study - The Lancet
International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study - The Lancet

Pathological complete response after neoadjuvant immunotherapy for a  patient with microsatellite instability locally advanced rectal cancer:  should we adapt our standard management for these patients? - European  Journal of Cancer
Pathological complete response after neoadjuvant immunotherapy for a patient with microsatellite instability locally advanced rectal cancer: should we adapt our standard management for these patients? - European Journal of Cancer

Frontiers | Is There a Place for Immunotherapy for Metastatic  Microsatellite Stable Colorectal Cancer? | Immunology
Frontiers | Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer? | Immunology

Prognosis of microsatellite instability and/or mismatch repair deficiency  stage III colon cancer patients after disease recurrence following adjuvant  treatment: results of an ACCENT pooled analysis of seven studies - Annals  of Oncology
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies - Annals of Oncology

Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal  cancer and a perspective on resistance mechanisms | British Journal of  Cancer
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms | British Journal of Cancer

MSI/MSS Colorectal Cancers - TRanslational ONCOlogy
MSI/MSS Colorectal Cancers - TRanslational ONCOlogy

Immunotherapy in the treatment of colorectal cancer: a new kid on the block
Immunotherapy in the treatment of colorectal cancer: a new kid on the block

Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix  metalloproteinase‐mediated activation of TGFβ | EMBO Molecular Medicine
Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ | EMBO Molecular Medicine

Immunotherapy Combination Approved for Colorectal Cancer - National Cancer  Institute
Immunotherapy Combination Approved for Colorectal Cancer - National Cancer Institute

Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the  DNA Microsatellite Status in Human Colorectal Cancer - The Journal of  Molecular Diagnostics
Clinical Performance of the Idylla MSI Test for a Rapid Assessment of the DNA Microsatellite Status in Human Colorectal Cancer - The Journal of Molecular Diagnostics

VIB - Biocartis ontvangt subsidie voor ontwikkeling van volledig  geautomatiseerde MSI test
VIB - Biocartis ontvangt subsidie voor ontwikkeling van volledig geautomatiseerde MSI test

Colorectal Cancer
Colorectal Cancer

Frontline pembrolizumab delays disease progression of colorectal cancer  patients with a high microsatellite instability - BJMO
Frontline pembrolizumab delays disease progression of colorectal cancer patients with a high microsatellite instability - BJMO

Frontiers | Re-education of the Tumor Microenvironment With Targeted  Therapies and Immunotherapies | Immunology
Frontiers | Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies | Immunology

Revolutionary diagnostic cancer test - VIB
Revolutionary diagnostic cancer test - VIB

Comparison of microsatellite instability detection by immunohistochemistry  and molecular techniques in colorectal and endometrial cancer | Scientific  Reports
Comparison of microsatellite instability detection by immunohistochemistry and molecular techniques in colorectal and endometrial cancer | Scientific Reports

Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer  | NEJM
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM

Immunotherapy in colorectal cancer treatment: actual landscape and future  perspectives
Immunotherapy in colorectal cancer treatment: actual landscape and future perspectives